Samsung Medical Center
| République de Corée | Turquie | Espagne | |
| Physiothérapie | de $100 | de $50 | de $300 |
| Thérapie par cellules souches pour la spondylarthrite ankylosante | - | de $7,000 | de $9,000 |
| Thérapie biologique | - | de $5,500 | de $15,000 |
Dr. Jang Hyo Kim is an orthopedic surgeon at Leadheal Hospital in Seoul. He specializes in joint preservation and complex reconstruction. He completed a fellowship in Ilizarov external fixation surgery in Russia. Dr. Kim currently serves as the Joint Center Director at Very Good Hospital. He is an adjunct professor at Kyung Hee University.
Le Dr Ahn Tae Hoon a été formé au Montreal Heart Institute et dirige le centre cardiovasculaire de l'hôpital Naeun.
Directeur du centre orthopédique de l'hôpital Naeun – spécialisé dans les troubles articulaires et la chirurgie arthroscopique.
L'assurance maladie nationale de Corée du Sud couvre les produits biologiques pour la spondylarthrite ankylosante dans le cadre du programme pour les maladies rares et incurables (RID). Les patients ne paient généralement que 10 % des coûts de traitement. La couverture nécessite des critères cliniques spécifiques tels qu'une sacro-iliite active à l'imagerie et l'échec des thérapies conventionnelles après 3 mois.
Avis d'expert Bookimed : Les patients doivent privilégier les hôpitaux universitaires comme le Severance ou l'Asan Medical Center pour l'approbation initiale des produits biologiques. Ces centres académiques gèrent des volumes élevés de patients et disposent de systèmes rationalisés pour l'enregistrement RID. Les grands établissements utilisent également des systèmes numériques comme BESTcare pour suivre l'historique des traitements et éviter les erreurs de documentation lors des recours.
Consensus des patients : Les patients notent qu'il est essentiel de documenter chaque échec médicamenteux pour l'approbation de l'assurance. Beaucoup constatent que, bien que les coûts initiaux des médicaments semblent élevés, le plafond de co-paiement de 10 % rend la thérapie biologique à long terme abordable.
South Korean clinics treat ankylosing spondylitis using international protocols. These combine anti-inflammatory medication, biologic agents, and intensive physiotherapy. Leading Seoul hospitals use TNF-alpha inhibitors and IL-17 inhibitors to manage spinal inflammation effectively. Specialised orthopaedic centres provide spinal diagnostics and rehabilitation within JCI-accredited facilities.
Bookimed Expert Insight: South Korea is known for high-volume digital hospitals. Seoul National University Bundang Hospital was the country's first digital facility. This technology allows for precise tracking of chronic spinal conditions. Patients benefit from centres like Wiltse Memorial Hospital. Specialists there focus exclusively on spinal diseases, performing about 2,500 operations annually for complex cases.
Asan Medical Center, Samsung Medical Center, and Seoul National University Hospital are the top hospitals for ankylosing spondylitis in South Korea. These tertiary centres provide multidisciplinary care. They combine rheumatology, orthopaedics, and diagnostics like MRI. Most lead national research into biologic therapies.
Bookimed Expert Insight: Samsung Medical Center serves over 2 million patients annually. It holds multiple Newsweek World's Best Hospital rankings. This high volume helps doctors gain experience in complex inflammatory cases. Patients should look for these certifications when choosing a clinic for long-term biologic management.
Patient Consensus: Patients note that major Seoul university hospitals provide the best access to inflammatory marker testing and biologics. For Australians, seeking hospitals with dedicated international patient centres is essential for English translation and coordinated care.
Modern biologic drugs including TNF inhibitors and IL-17 inhibitors are widely available in South Korea. JCI-accredited facilities in Seoul provide these therapies alongside biosimilars. Access often requires proof of high disease activity and previous conventional treatment failure.
Bookimed Expert Insight: South Korea ranks 7th globally for medical requests. Specialised orthopaedic hospitals like Wiltse Memorial serve 50,000+ patients annually. This massive volume means clinicians often have more experience with biologic titration. Patients should note that Samsung Medical Center and Asan Medical Center are world-ranked hospitals. This reflects their high standard of rheumatology care.
Patient Consensus: Patients note that confirming local drug availability and prescribing practices is essential. It is highly recommended to bring a full Australian medical history. This helps Korean doctors match existing biologic protocols.
Genetic testing supports ankylosing spondylitis diagnosis in South Korea but does not confirm it alone. Doctors use the HLA-B27 test. This result serves as supportive evidence alongside MRI scans and clinical history. Diagnostic protocols at Seoul centres follow international standards for accuracy.
Bookimed Expert Insight: Small clinics often focus on physiotherapy. In contrast, major Seoul centres like Severance Hospital or Samsung Medical Center use large-scale diagnostic data. These hospitals manage millions of outpatients annually. This allows specialists to distinguish ankylosing spondylitis from similar spinal conditions using specialised MRI protocols.
Patient Consensus: Patients note that doctors in the Republic of Korea focus on imaging results over blood tests. They suggest asking specialists exactly how imaging and clinical signs confirm the diagnosis.